Literature DB >> 9585359

Association between centromeric deletions of the SMN gene and sporadic adult-onset lower motor neuron disease.

B Moulard1, F Salachas, B Chassande, V Briolotti, V Meininger, A Malafosse, W Camu.   

Abstract

The telomeric copy (t) of the survival motor neuron (SMN) gene is homozygously deleted in more than 90% of patients with infantile motor neuron disease (MND). In the general population, no homozygous SMNt deletion has been found, whereas 5% of centromeric SMN (SMNc) deletions can be observed. Although SMNt deletions appear causal for infantile and at least some adult-onset spinal muscular atrophy (SMA) (type IV), the respective role of SMN deletions remains unclear in adult-onset MNDs. We studied SMN gene in three different groups of patients with adult-onset MNDs. In sporadic amyotrophic lateral sclerosis (ALS; n = 177) and familial ALS (n = 66), no SMNt deletion had been found, and the frequency of SMNc deletions was not increased. Conversely, among the 14 patients with sporadic pure lower MND (LMND), we found 2 patients with homozygous SMNt deletions (14%) and 5 patients with homozygous SMNc deletions (36%). These data suggest that (1) SMNt deletions do not account for the major part, if any, of adult-onset LMND cases; and (2) SMNc deletions act as a susceptibility factor for LMNDs in adults. The clinical and genetic heterogeneity of LMND cases, including SMA type IV, are yet to be unexplained. Further studies on large groups of adult-onset LMND patients are warranted to refine its nosology.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9585359     DOI: 10.1002/ana.410430513

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  7 in total

1.  Homozygous SMN2 deletion is a protective factor in the Swedish ALS population.

Authors:  Philippe Corcia; Caroline Ingre; Helene Blasco; Rayomand Press; Julien Praline; Catherine Antar; Charlotte Veyrat-Durebex; Yves-Olivier Guettard; William Camu; Peter M Andersen; Patrick Vourc'h; Christian R Andres
Journal:  Eur J Hum Genet       Date:  2012-01-25       Impact factor: 4.246

Review 2.  Measures and markers in amyotrophic lateral sclerosis.

Authors:  Merit Cudkowicz; Muhammad Qureshi; Jeremy Shefner
Journal:  NeuroRx       Date:  2004-04

Review 3.  Genetics of Amyotrophic Lateral Sclerosis.

Authors:  Mehdi Ghasemi; Robert H Brown
Journal:  Cold Spring Harb Perspect Med       Date:  2018-05-01       Impact factor: 6.915

Review 4.  The Genetics of Spinal Muscular Atrophy: Progress and Challenges.

Authors:  Michelle A Farrar; Matthew C Kiernan
Journal:  Neurotherapeutics       Date:  2015-04       Impact factor: 7.620

5.  Homozygous SMN2 deletion is a major risk factor among twenty-five Korean sporadic amyotrophic lateral sclerosis patients.

Authors:  Jun-Beom Lee; Kyung-A Lee; Ji-Man Hong; Gyoung-Im Suh; Young-Chul Choi
Journal:  Yonsei Med J       Date:  2012-01       Impact factor: 2.759

6.  Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis.

Authors:  John E Landers; Judith Melki; Vincent Meininger; Jonathan D Glass; Leonard H van den Berg; Michael A van Es; Peter C Sapp; Paul W J van Vught; Diane M McKenna-Yasek; Hylke M Blauw; Ting-Jan Cho; Meraida Polak; Lijia Shi; Anne-Marie Wills; Wendy J Broom; Nicola Ticozzi; Vincenzo Silani; Aslihan Ozoguz; Ildefonso Rodriguez-Leyva; Jan H Veldink; Adrian J Ivinson; Christiaan G J Saris; Betsy A Hosler; Alayna Barnes-Nessa; Nicole Couture; John H J Wokke; Thomas J Kwiatkowski; Roel A Ophoff; Simon Cronin; Orla Hardiman; Frank P Diekstra; P Nigel Leigh; Christopher E Shaw; Claire L Simpson; Valerie K Hansen; John F Powell; Philippe Corcia; François Salachas; Simon Heath; Pilar Galan; Franck Georges; H Robert Horvitz; Mark Lathrop; Shaun Purcell; Ammar Al-Chalabi; Robert H Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2009-05-18       Impact factor: 11.205

Review 7.  Copy Number Variations in the Survival Motor Neuron Genes: Implications for Spinal Muscular Atrophy and Other Neurodegenerative Diseases.

Authors:  Matthew E R Butchbach
Journal:  Front Mol Biosci       Date:  2016-03-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.